Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Endologix Inc Issues Q2 2013 Revenue Guidance Above Analysts' Estimates; Raises FY 2013 Revenue Guidance; Lowers FY 2013 Earnings Guidance


Monday, 1 Jul 2013 08:02am EDT 

Endologix Inc announced that for second quarter of 2013, it expects global revenue of approximately $34.0 million. For fiscal 2013, it expects revenue to be in the range of $128-$134 million, adjusted net (loss) per share (EPS) (non-GAAP) to be in the range of $(0.18) to $(0.22) per share, adjusted EBITDA per share (non-GAAP) to be in the range of $(0.02) to $0.02 per share. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $31.2 million for second quarter of 2013; revenue of $130 million, EPS of $(0.15) for fiscal 2013. 

Company Quote

13.88
-0.34 -2.39%
11:14am EDT